Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study
- Resource Type
- Article
- Authors
- Xu, Jianming ; Shen, Lin; Bai, Chunmei; Wang, Wei; Li, Jie; Yu, Xianjun; Li, Zhiping; Li, Enxiao; Yuan, Xianglin; Chi, Yihebali; Yin, Yongmei; Lou, Wenhui; Xu, Nong; Bai, Yuxian; Zhang, Tao; Xiu, Dianrong; Wang, Xiuwen; Yuan, Ying; Chen, Jia; Qin, Shukui; Jia, Ru; Lu, Ming; Cheng, Yuejuan; Zhou, Zhiwei; Li, Jing; He, James; Su, Weiguo
- Source
- In The Lancet Oncology November 2020 21(11):1489-1499
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045